[HTML][HTML] Parkinson disease-associated cognitive impairment
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors
C Wang, DM Holtzman - Neuropsychopharmacology, 2020 - nature.com
As we age, we experience changes in our nighttime sleep and daytime wakefulness.
Individuals afflicted with Alzheimer's disease (AD) can develop sleep problems even before …
Individuals afflicted with Alzheimer's disease (AD) can develop sleep problems even before …
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
KA Jellinger, AD Korczyn - BMC medicine, 2018 - Springer
Abstract Background Dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD), which share many clinical, neurochemical, and morphological features, have been …
(PDD), which share many clinical, neurochemical, and morphological features, have been …
New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes
SM Fereshtehnejad, SR Romenets, JBM Anang… - JAMA …, 2015 - jamanetwork.com
Importance There is increasing evidence that Parkinson disease (PD) is heterogeneous in
its clinical presentation and prognosis. Defining subtypes of PD is needed to better …
its clinical presentation and prognosis. Defining subtypes of PD is needed to better …
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies
KA Jellinger - Journal of neural transmission, 2018 - Springer
Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015
LM Chahine, AW Amara, A Videnovic - Sleep medicine reviews, 2017 - Elsevier
Sleep disorders are among the most common non-motor manifestations in Parkinson's
disease (PD) and have a significant negative impact on quality of life. While sleep disorders …
disease (PD) and have a significant negative impact on quality of life. While sleep disorders …
Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials
RB Postuma, JF Gagnon, JA Bertrand… - Neurology, 2015 - AAN Enterprises
Objective: To precisely delineate clinical risk factors for conversion from idiopathic REM
sleep behavior disorder (RBD) to Parkinson disease, dementia with Lewy bodies, and …
sleep behavior disorder (RBD) to Parkinson disease, dementia with Lewy bodies, and …
Identifying prodromal Parkinson's disease: pre‐motor disorders in Parkinson's disease
Increasing recognition that Parkinson's disease (PD) may start outside of the substantia
nigra has led to a rapidly expanding effort to define prodromal stages of PD, before motor …
nigra has led to a rapidly expanding effort to define prodromal stages of PD, before motor …
The MoCA: well-suited screen for cognitive impairment in Parkinson disease
Objective: To establish the diagnostic accuracy of the Montreal Cognitive Assessment
(MoCA) when screening externally validated cognition in Parkinson disease (PD), by …
(MoCA) when screening externally validated cognition in Parkinson disease (PD), by …
Montreal Cognitive Assessment (MoCA): concept and clinical review
P Julayanont, ZS Nasreddine - Cognitive screening instruments: A …, 2017 - Springer
Abstract The Montreal Cognitive Assessment (MoCA) is a cognitive screening instrument
developed to detect mild cognitive impairment (MCI). It is a simple 10 min paper and pencil …
developed to detect mild cognitive impairment (MCI). It is a simple 10 min paper and pencil …